Investing.com -- Chemed Corporation (NYSE:CHE)股价下跌14%,此前该公司报告佛罗里达州医疗保险收治人数不及预期,导致其VITAS子公司预计收入受限。 这家医疗服务提供商现在预计,2025财政年度与佛罗里达州合并项目(不包括塔拉哈西)相关的医疗保险上限收入限制为1800万美元至2500万美元。此前对2025年收益的指引并未包含任何佛罗里达州医疗保险上限...
Source LinkInvesting.com -- Chemed Corporation (NYSE:CHE)股价下跌14%,此前该公司报告佛罗里达州医疗保险收治人数不及预期,导致其VITAS子公司预计收入受限。 这家医疗服务提供商现在预计,2025财政年度与佛罗里达州合并项目(不包括塔拉哈西)相关的医疗保险上限收入限制为1800万美元至2500万美元。此前对2025年收益的指引并未包含任何佛罗里达州医疗保险上限...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.